Associations of Ten Insulin Resistance Surrogate Indices with Incident Ischaemic Stroke: A Prospective Analysis of the UK Biobank
This prospective analysis of 317,413 UK Biobank participants demonstrates that multiple insulin resistance surrogate indices, particularly eGDR, TyG-WC, TyG-WHtR, and METS-IR, are associated with incident ischaemic stroke risk, though their moderate predictive performance currently limits immediate clinical application.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Stroke remains one of the world's most persistent health challenges, a leading cause of death and long-term disability that places a heavy burden on families and societies. Among the different types of stroke, the ischaemic variety is the most common, occurring when a blood clot blocks the flow of blood to the brain. While doctors have long known that high blood pressure and smoking are major culprits, a deeper underlying driver has gained increasing attention: insulin resistance. This is a condition where the body's cells stop responding efficiently to insulin, a hormone that helps manage sugar in the blood. When this system falters, it often sets off a chain reaction involving obesity, high blood pressure, and unhealthy cholesterol levels, all of which strain the heart and blood vessels. Because the gold-standard test for measuring insulin resistance is invasive and expensive, researchers rely on simpler calculations—surrogate indices—that use routine blood tests and body measurements to estimate the risk. However, it has remained unclear which of these many different calculation methods is the most accurate at predicting who will suffer a stroke in the future.
To answer this question, a team of researchers turned to the UK Biobank, a massive database containing health information from over half a million volunteers. They focused specifically on 317,413 adults who were free of stroke when they first joined the study. The team gathered a wide array of data, including age, sex, lifestyle habits like smoking and exercise, and detailed medical records. From this information, they calculated ten different estimates of insulin resistance. Some of these estimates looked at how the body handles sugar and fat, while others combined those numbers with measurements of body shape, such as waist size or body mass index. The researchers then tracked these participants for many years, watching to see who developed an ischaemic stroke. During this follow-up period, 5,035 participants, or about 1.6 percent of the group, experienced a stroke.
The study revealed a clear pattern in how these different estimates related to stroke risk. One specific measure, known as the estimated glucose disposal rate, showed a protective effect: people with higher scores on this scale were less likely to have a stroke. In contrast, the other nine measures generally pointed in the opposite direction. Higher scores on these indices, which often reflect greater insulin resistance or excess fat around the waist, were linked to a higher risk of stroke. The researchers found that the estimates which incorporated waist circumference or a ratio of waist to height tended to be the strongest predictors. For instance, a measure combining triglycerides and glucose with waist size showed a particularly strong link to future stroke events. When the team looked at the data in detail, they saw that as the levels of these risk markers rose, the likelihood of a stroke increased in a steady, dose-dependent manner.
However, the researchers were careful to note that while these markers are useful, they are not perfect crystal balls. When they tested how well these indices could predict a stroke five or ten years down the line, the results were modest. The best-performing measure could distinguish between those who would and would not have a stroke with only moderate accuracy. This suggests that while these calculations provide valuable clues, they are not yet strong enough to be used as standalone tools for diagnosing risk in a single individual. The study also uncovered interesting differences based on who was being studied. The link between insulin resistance and stroke was often stronger in women than in men, and it was more pronounced in adults under the age of sixty. In older adults, other factors like long-standing high blood pressure or heart rhythm problems seemed to overshadow the influence of insulin resistance, making the connection harder to detect in that age group.
Ultimately, this large-scale analysis confirms that insulin resistance is a significant player in the development of ischaemic stroke. It highlights that the way we measure this resistance matters, with methods that account for where fat is stored on the body appearing to offer the clearest warning signs. While these findings do not yet provide a simple fix or a definitive test for the general public, they offer a refined map for understanding risk. The study suggests that for younger people and women, paying close attention to metabolic health and body shape could be especially important for preventing stroke. Before these tools can be used routinely in clinics to guide treatment, however, more research is needed to confirm these results across different populations and to see if they add enough value beyond the traditional risk factors doctors already monitor.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.